Literature DB >> 12853713

Thrombin generation in platelet-rich plasma as a tool for the detection of hypercoagulability in young stroke patients.

C G Faber1, J Lodder, F Kessels, J Troost.   

Abstract

The time course of the concentration of active thrombin in clotting plasma (the thrombogram) was measured by subsampling from platelet-rich plasma (PRP) and continuous chromogenic measurement of platelet-poor plasma (PPP) in 41 stroke patients under the age of 50, in whom stroke could not be attributed to cardioembolic disease, arterial dissection or vasculitis. A significant increase in the area under the thrombogram (endogenous thrombin potential, ETP) was seen in 23 patients. In 9 of them, ETP was increased in PRP but normal in PPP. High ETP in PRP was significantly associated with stroke, both in the middle and in the highest tercile of the ETP (odds ratio 5.1, range 1.8-15.1, and 3.7, range 1.3-10.3, respectively). A decreased sensitivity to the inhibitory action of thrombomodulin (TM) on thrombin generation was observed in 5 of 37 cases. No further definition of the cause of increased thrombin generation or TM resistance was attempted, except for the role of von Willebrand factor (vWF). ETP in PRP, platelet-derived procoagulant activity and vWF were correlated and higher in patients than in controls (p=0.002, p=0.045 and p=0.0006, respectively). This confirms the correlation between vWF level and stroke at young age found in epidemiological studies. It suggests that the role of vWF in thrombin generation, which has been demonstrated in vitro, may be the underlying mechanism of this correlation. In summary, hypercoagulability, defined as an increased capacity of the platelet plasma system to form thrombin, is found in over half of the patients under 50 years with an otherwise unexplained stroke. Sometimes it is due to increased plasma factor activity, sometimes to an increased procoagulant activity of the platelets. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853713     DOI: 10.1159/000071642

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  11 in total

1.  Thrombophilias and stroke: diagnosis, treatment, and prognosis.

Authors:  Madeline C Fields; Steven R Levine
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

2.  On-chip titration of an anticoagulant argatroban and determination of the clotting time within whole blood or plasma using a plug-based microfluidic system.

Authors:  Helen Song; Hung-Wing Li; Matthew S Munson; Thuong G Van Ha; Rustem F Ismagilov
Journal:  Anal Chem       Date:  2006-07-15       Impact factor: 6.986

3.  Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events.

Authors:  Matthew Gissel; Anetta Undas; Agnieszka Slowik; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  Thromb Res       Date:  2010-08-14       Impact factor: 3.944

4.  Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin.

Authors:  Anton A Vrij; Ardi Oberndorff-Klein-Woolthuis; Gerard Dijkstra; Andrea E de Jong; Rob Wagenvoord; Hendrik C Hemker; Reinhold W Stockbrügger
Journal:  J Thromb Thrombolysis       Date:  2007-02-17       Impact factor: 2.300

5.  Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion.

Authors:  Alice Trinchero; Marina Marchetti; Cinzia Giaccherini; Carmen J Tartari; Laura Russo; Anna Falanga
Journal:  Blood Transfus       Date:  2016-10-04       Impact factor: 3.443

6.  Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.

Authors:  W O Tobin; J A Kinsella; G F Kavanagh; J S O'Donnell; R A McGrath; D R Collins; T Coughlan; D O'Neill; B Egan; S Tierney; T M Feeley; R P Murphy; Dominick J H McCabe
Journal:  J Neurol       Date:  2012-10-14       Impact factor: 4.849

7.  Thrombin inhibitory activity of some polyphenolic compounds.

Authors:  M Bijak; R Ziewiecki; J Saluk; M Ponczek; I Pawlaczyk; H Krotkiewski; B Wachowicz; P Nowak
Journal:  Med Chem Res       Date:  2013-10-16       Impact factor: 1.965

8.  Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk.

Authors:  Elena N Lipets; Fazoil I Ataullakhanov
Journal:  Thromb J       Date:  2015-01-23

9.  Genetic Determinants of Thrombin Generation and Their Relation to Venous Thrombosis: Results from the GAIT-2 Project.

Authors:  Laura Martin-Fernandez; Andrey Ziyatdinov; Marina Carrasco; Juan Antonio Millon; Angel Martinez-Perez; Noelia Vilalta; Helena Brunel; Montserrat Font; Anders Hamsten; Juan Carlos Souto; José Manuel Soria
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

10.  Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA.

Authors:  Sarah Goldman; Shannon M Prior; Jan P Bembenek; Maciej Niewada; Elżbieta Broniatowska; Anna Członkowska; Saulius Butenas; Anetta Undas
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.